Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-01-30
2007-01-30
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S257000, C544S258000, C544S259000, C544S260000
Reexamination Certificate
active
10070530
ABSTRACT:
Disclosed are compounds of Formulae (Ia), (Ib), (Ic), (Id) wherein: W is NH, S, SO, or SO2; R2is (un)substituted aryl, (un)substituted heteroaryl, or (un)substituted carbocycle or heterocycle; Q is hydrogen or lower alkyl; R4and R6are the same or different and represent hydrogen, halogen, lower alkyl, lower alkoxy, (un)substituted aryl, (un)substituted heteroaryl, (un)substituted arylalkyl or (un)substituted heteroarylalkyl; and R8is hydrogen, lower alkyl or an (un)substituted carbocyclic group containing from 3–7 members, up to two of which members are optionally hetero atoms selected from oxygen and nitrogen; or R8is (un)substituted aryl, (un)substituted heteroaryl, (un)substituted arylalkyl or (un)substituted heteroarylalkyl. These compounds are useful for treating cell proliferative disorders, such as cancer and restenosis. These compounds are potent inhibitors of cyclin-dependent kinases (cdks) and growth factor-mediated kinases. The present invention also provides a method of treating cell proliferative disorders. Also provided by the present invention is a pharmaceutically acceptable composition containing a compound of Formula (I).
REFERENCES:
patent: 0 837 063 (1998-04-01), None
patent: WO 96/40142 (1996-12-01), None
patent: WO 2002/076985 (2002-10-01), None
Wolff, Manfred E. “Burger's Medicinal Chemistry, 5ed, Part I”, John Wiley & Sons, 1995, pp. 975-977.
Banker, G.S. et al, “Modern Pharmaceutics, 3ed.”, Marcel Dekker, New York, 1996, pp. 451 and 596.
PCT/SU00/17037 International Search Report.
M. Ott, “Zur Synthese des 4-Amino-7-oxo-7,8-dihydropteridin-N-8-beta-D-ribofuranosids-ein strukturanaloges Nucleosid des Adenosins”, Chem. Ber., 1974, 339-361, vol. 107.
H. Hiroto, “Ethynylpyrimidine Derivative” Patent Abstracts of Japan, Mar. 26, 1999, vol. 1999, No. 8.
S. Tadashi, “Penicillin Derivatives” Patent Abstracts of Japan, Oct. 30, 1978, vol. 003, No. 003.
Denny William Alexander
Dobrusin Ellen
Kramer James Bernard
McNamara Dennis Joseph
Rewcastle Gordon William
Jaisle Cecilia
Rao Deepak
Warner-Lambert & Company
Yakovleva Galina M.
Zielinski Bryan C.
LandOfFree
Pteridinones as kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pteridinones as kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pteridinones as kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3825853